Literature DB >> 15103492

IL-1beta induces an exaggerated pro- and anti-inflammatory response in peritoneal macrophages of children compared with adults.

Katherine A Barsness1, Denis D Bensard, David A Partrick, Casey M Calkins, Richard J Hendrickson, Anirban Banerjee, Robert C McIntyre.   

Abstract

Children have a lower incidence of acute lung injury (ALI) compared with adults. Because ALI appears to be the end result of systemic hyperinflammation, children may either have 1) an attenuated pro-inflammatory response or 2) an augmented anti-inflammatory response compared with adults. The purpose of this study was to determine the IL-1-induced pro- and anti-inflammatory response of pediatric vs. adult peritoneal macrophages (PMs). We hypothesized that pediatric PMs would have an enhanced anti-inflammatory response compared with adult PMs. Human PMs were collected during elective laparoscopic procedures, cultured, and stimulated with IL-1beta. IL-6, IL-8, IL-10, and TNFalpha production were determined by ELISA. Statistical analyses were by ANOVA; a P <0.05 was significant. Our results showed that IL-1beta induced an 11-fold increase in IL-10 production in pediatric PMs (659+/-103 vs. 60+/-25 control, P <0.05). There was no IL-10 production in IL-1beta-stimulated adult PMs. IL-1beta-induced TNF production was greater in children compared with adults (2152+/-166 vs. 592+/-188, P <0.05). Similarly, IL-1beta-induced IL-6 production was greater in pediatric PMs compared with adults (532+/-3 vs. 444+/-52, P <0.05). There was no difference in IL-1beta-induced IL-8 production in children compared with adults. The IL-10:TNFalpha ratio after IL-1beta stimulation was 0.306+/-0.056 in pediatric macrophages and 0.020+/-0.015 in adult macrophages ( P<0.01). In conclusion, IL-1beta-induced IL-6 and TNFalpha production were greater in pediatric than adult PMs. Furthermore, pediatric PMs had an 11-fold increase in IL-1beta-induced IL-10 production, while adult PMs did not produce IL-10. Therefore, IL-1beta induces both a pro- and an anti-inflammatory response in pediatric PMs, whereas adult PMs produce only pro-inflammatory cytokines in response to IL-1beta. The exaggerated anti-inflammatory IL-10 response in children may be an important factor in the observed differences in ALI between children and adults.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103492     DOI: 10.1007/s00383-003-1118-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  34 in total

1.  Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome.

Authors:  L Armstrong; A B Millar
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

2.  Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice.

Authors:  Ulrich A Maus; M Audrey Koay; Tim Delbeck; Matthias Mack; Monika Ermert; Leander Ermert; Timothy S Blackwell; John W Christman; Detlef Schlöndorff; Werner Seeger; Jürgen Lohmeyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-06       Impact factor: 5.464

3.  Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae.

Authors:  Reinhard Berner; Patrick Welter; Matthias Brandis
Journal:  Pediatr Res       Date:  2002-03       Impact factor: 3.756

4.  The role of interleukin-10 in critical illness.

Authors:  Steven M. Opal; Christian E. Huber
Journal:  Curr Opin Infect Dis       Date:  2000-06       Impact factor: 4.915

5.  Jack A. Barney Resident Research Award winner. The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure.

Authors:  D A Partrick; F A Moore; E E Moore; W L Biffl; A Sauaia; C C Barnett
Journal:  Am J Surg       Date:  1996-11       Impact factor: 2.565

6.  The feasibility of conducting clinical trials in infants and children with acute respiratory failure.

Authors:  Adrienne G Randolph; Kathleen L Meert; Mary E O'Neil; James H Hanson; Peter M Luckett; John H Arnold; Rainer G Gedeit; Peter N Cox; Joan S Roberts; Shekhar T Venkataraman; Peter W Forbes; Ira M Cheifetz
Journal:  Am J Respir Crit Care Med       Date:  2003-02-25       Impact factor: 21.405

Review 7.  Therapeutic implications of interleukin-10 in surgical disease.

Authors:  C H Selzman; B D Shames; S A Miller; E J Pulido; X Meng; R C McIntyre; A H Harken
Journal:  Shock       Date:  1998-11       Impact factor: 3.454

8.  Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994.

Authors:  B J Stoll; R C Holman; A Schuchat
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

Review 9.  Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock.

Authors:  Joseph A Carcillo; Alan I Fields
Journal:  Crit Care Med       Date:  2002-06       Impact factor: 7.598

10.  Altered neutrophil function in the neonate protects against sepsis-induced lung injury.

Authors:  Casey M Calkins; Denis D Bensard; David A Partrick; Frederick M Karrer; Robert C McIntyre
Journal:  J Pediatr Surg       Date:  2002-07       Impact factor: 2.545

View more
  12 in total

Review 1.  The pediatric sepsis biomarker risk model: potential implications for sepsis therapy and biology.

Authors:  Matthew N Alder; Christopher J Lindsell; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2014-04-22       Impact factor: 5.091

2.  Cystogastrostomy: a valid option for treating pancreatic pseudocysts of children in developing countries.

Authors:  Simmi K Ratan; Kamal Nain Rattan; Seema Rohilla; Sarita Magu
Journal:  Pediatr Surg Int       Date:  2006-05-03       Impact factor: 1.827

3.  Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice.

Authors:  Richard A Johnston; Joseph P Mizgerd; Lesley Flynt; Lee J Quinton; Erin S Williams; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

4.  Ventilator-induced lung injury. Similarity and differences between children and adults.

Authors:  Martin C J Kneyber; Haibo Zhang; Arthur S Slutsky
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

5.  Pediatric Sepsis - Part I: "Children are not small adults!"

Authors:  Derek S Wheeler; Hector R Wong; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

6.  Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT.

Authors:  Nigel J Hall; Frances C Sherratt; Simon Eaton; Isabel Reading; Erin Walker; Maria Chorozoglou; Lucy Beasant; Wendy Wood; Michael Stanton; Harriet J Corbett; Dean Rex; Natalie Hutchings; Elizabeth Dixon; Simon Grist; William Van't Hoff; Esther Crawley; Jane Blazeby; Bridget Young
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

Review 7.  Human malarial disease: a consequence of inflammatory cytokine release.

Authors:  Ian A Clark; Alison C Budd; Lisa M Alleva; William B Cowden
Journal:  Malar J       Date:  2006-10-10       Impact factor: 2.979

8.  CONTRACT Study - CONservative TReatment of Appendicitis in Children (feasibility): study protocol for a randomised controlled Trial.

Authors:  Natalie Hutchings; Wendy Wood; Isabel Reading; Erin Walker; Jane M Blazeby; William Van't Hoff; Bridget Young; Esther M Crawley; Simon Eaton; Maria Chorozoglou; Frances C Sherratt; Lucy Beasant; Harriet Corbett; Michael P Stanton; Simon Grist; Elizabeth Dixon; Nigel J Hall
Journal:  Trials       Date:  2018-03-02       Impact factor: 2.279

Review 9.  Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

Authors:  David S Fedson
Journal:  Influenza Other Respir Viruses       Date:  2009-07       Impact factor: 4.380

Review 10.  Influenza, evolution, and the next pandemic.

Authors:  David S Fedson
Journal:  Evol Med Public Health       Date:  2018-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.